An adverse reaction to buprenorphine/naloxone induction in prison: A case report

Josiah D. Rich, Michelle McKenzie, Samuel Dickman, Jeffrey Bratberg, Joshua D. Lee, Robert P. Schwartz

Research output: Contribution to journalArticle

Abstract

Buprenorphine is an effective treatment for opiate dependence. Prisoners with histories of opiate dependence who are inducted on buprenorphine prior to release are at decreased risk of post-release relapse and overdose, yet many clinicians are unaware of the risks related to buprenorphine induction for non-opiate tolerant patients, especially those on other psychotropic medications. The authors report a case of probable non-lethal overdose during dose induction of a non-tolerant prisoner and discuss appropriate dosing under similar circumstances.

Original languageEnglish (US)
Pages (from-to)199-200
Number of pages2
JournalAddictive Disorders and their Treatment
Volume10
Issue number4
DOIs
StatePublished - Dec 2011

Keywords

  • Words: buprenorphine
  • adverse event
  • naloxone
  • opiate addiction
  • prison

ASJC Scopus subject areas

  • Medicine (miscellaneous)
  • Psychiatry and Mental health

Fingerprint Dive into the research topics of 'An adverse reaction to buprenorphine/naloxone induction in prison: A case report'. Together they form a unique fingerprint.

  • Cite this

    Rich, J. D., McKenzie, M., Dickman, S., Bratberg, J., Lee, J. D., & Schwartz, R. P. (2011). An adverse reaction to buprenorphine/naloxone induction in prison: A case report. Addictive Disorders and their Treatment, 10(4), 199-200. https://doi.org/10.1097/ADT.0b013e3182133949